يعرض 1 - 20 نتائج من 30 نتيجة بحث عن '"Cárdenas Palacio, Carlos"', وقت الاستعلام: 0.49s تنقيح النتائج
  1. 1
    Dissertation/ Thesis

    المساهمون: Cárdenas Parra, Luis Fernando, López Velásquez, Norman Darío, Strange, Bryan Andrew, Báez Buitrago, Sandra Jimena, Monsalve Duarte, Guillermo Alfonso, Facultad de Ciencias Sociales::Neurociencia y Comportamiento

    وصف الملف: 163 páginas; application/pdf

    Relation: Abur, D., Lupiani, A. A., Hickox, A. E., Shinn-Cunningham, B. G., & Stepp, C. E. (2018). Loudness perception of pure tones in Parkinson’s disease. Journal of Speech, Language, and Hearing Research, 61(6), 1487–1496. https://doi.org/10.1044/2018_JSLHR-H-17-0382; Abur, D., Subaciute, A., Daliri, A., Lester-Smith, R. A., Lupiani, A. A., Cilento, D., Enos, N. M., Weerathunge, H. R., Tardif, M. C., & Stepp, C. E. (2021). Feedback and feedforward auditory-motor processes for voice and articulation in parkinson’s disease. Journal of Speech, Language, and Hearing Research, 64(12), 4682-4694. https://doi.org/10.1044/2021_JSLHR-21-00153; Acosta, S. A., Tajiri, N., de la Pena, I., Bastawrous, M., Sanberg, P. R., Kaneko, Y., & Borlongan, C. V. (2015). Alpha-Synuclein as a pathological link between chronic traumatic brain injury and parkinson’s disease. Journal of Cellular Physiology, 230(5), 1024-1032. https://doi.org/10.1002/jcp.24830; Agüero, P., Tulli, J., Moscardi, G., González, E., & Uriz, A. (28 a 30 de septiembre de 2011). Estimating RASATI scores using acoustical parameters. Journal of Physics: Conference Series (JPCS), 332(012050), Mar del Plata, Argentina.; Akünal Türel, C., & Arıcan, M. (2023). Deep brain stimulation in idiopathic Parkinson’s disease. Northwestern Medical Journal, 3(1) 56-61. https://doi.org/10.54307/nwmj.2023.96967; Andersson, J. L. R., Hutton, C., Ashburner, J., Turner, R., & Friston, K. (2001). Modeling geometric deformations in EPI time series. NeuroImage, 13(5), 903-919. https://doi.org/10.1006/nimg.2001.0746; Armstrong, M. J., & Okun, M. S. (2020). Diagnosis and Treatment of Parkinson Disease: A Review. JAMA - Journal of the American Medical Association, 323(6), 548–560. https://doi.org/10.1001/jama.2019.22360; Arnold, C., Gehrig, J., Gispert, S., Seifried, C., & Kell, C. A. (2014). Pathomechanisms and compensatory efforts related to Parkinsonian speech. NeuroImage: Clinical, 4, 82–97. https://doi.org/10.1016/j.nicl.2013.10.016; Ashburner, J., & Friston, K. J. (2005). Unified segmentation. NeuroImage, 26(3), 839-851. https://doi.org/10.1016/j.neuroimage.2005.02.018; Aslan, S. N., & Karahalil, B. (2019). Oxidative stress and Parkinson disease. Ankara Universitesi Eczacilik Fakultesi Dergisi, 43(1), 94-116. https://doi.org/10.33483/jfpau.519964; Baumann, A., Nebel, A., Granert, O., Giehl, K., Wolff, S., Schmidt, W., Baasch, C., Schmidt, G., Witt, K., Deuschl, G., Hartwigsen, G., Zeuner, K. E., & van Eimeren, T. (2018). Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease. Neurorehabilitation and Neural Repair, 32(12), 1055–1066. https://doi.org/10.1177/1545968318812726; Bayram, E., Aslanbaba, E., & Akbostanci, M. C. (2019). Levodopa effect on spontaneous speech in Parkinson’s disease. Journal of Neurolinguistics, 51, 194–198. https://doi.org/10.1016/j.jneuroling.2019.03.001; Behroozmand, R., Phillip, L., Johari, K., Bonilha, L., Rorden, C., Hickok, G., & Fridriksson, J. (2018). Sensorimotor impairment of speech auditory feedback processing in aphasia. NeuroImage, 165, 102–111. https://doi.org/10.1016/j.neuroimage.2017.10.014; Behroozmand, R., Shebek, R., Hansen, D. R., Oya, H., Robin, D. A., Howard, M. A., & Greenlee, J. D. W. (2015). Sensory-motor networks involved in speech production and motor control: An fMRI study. NeuroImage, 109, 418–428. https://doi.org/10.1016/j.neuroimage.2015.01.040; Behzadi, Y., Restom, K., Liau, J., & Liu, T. T. (2007). A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage, 37(1), 90-101. https://doi.org/10.1016/j.neuroimage.2007.04.042; Bellomo, G., Paciotti, S., Gatticchi, L., & Parnetti, L. (2020). The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction. In Movement Disorders, 35(1), 34-44. https://doi.org/10.1002/mds.27895; Bhidayasiri, R., Chaudhuri, K. R., LeWitt, P., Martin, A., Boonpang, K., & Van Laar, T. (2015). Effective delivery of apomorphine in the management of parkinson disease: Practical considerations for clinicians and parkinson nurses. Clinical Neuropharmacology, 38(3), 89-103. https://doi.org/10.1097/WNF.0000000000000082; Biundo R, Weis L, Bostantjopoulou S, Stefanova E, Falup-Pecurariu C, Kramberger MG, Geurtsen GJ, Antonini A, Weintraub D, Aarsland D. MMSE and MoCA in Parkinsons disease and dementia with Lewy bodies: a multicenter 1-year follow-up study (2016). Journal of Neural Transmission (Vienna), 123(4), 431-438. doi:10.1007/s00702-016-1517-6.; Boersma, P. (2002). Praat, a system for doing phonetics by computer. Glot International, 5(9/10), 341-347.; Broadfoot, C. K., Abur, D., Hoffmeister, J. D., Stepp, C. E., & Ciucci, M. R. (2019). Research-Based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management. Perspectives of the ASHA Special Interest Groups, 4(5), 825–841. https://doi.org/10.1044/2019_pers-sig3-2019-0001; Bronstein, J. M., Tagliati, M., Alterman, R. L., Lozano, A. M., Volkmann, J., Stefani, A., Horak, F. B., Okun, M. S., Foote, K. D., Krack, P., Pahwa, R., Henderson, J. M., Hariz, M. I., Bakay, R. A., Rezai, A., Marks, W. J., Moro, E., Vitek, J. L., Weaver, F. M., … DeLong, M. R. (2011). Deep brain stimulation for Parkinson disease an expert consensus and review of key issues. Archives of Neurology,68(2), 165. https://doi.org/10.1001/archneurol.2010.260; Brown, S., Laird, A. R., Pfordresher, P. Q., Thelen, S. M., Turkeltaub, P., & Liotti, M. (2009). The somatotopy of speech: Phonation and articulation in the human motor cortex. Brain and Cognition, 70(1), 31–41. https://doi.org/10.1016/j.bandc.2008.12.006; Calhoun, V. D., Wager, T. D., Krishnan, A., Rosch, K. S., Seymour, K. E., Nebel, M. B., Mostofsky, S. H., Nyalakanai, P., & Kiehl, K. (2017). The impact of T1 versus EPI spatial normalization templates for fMRI data analyses. Human Brain Mapping, 38(11), 5331-5342. https://doi.org/10.1002/hbm.23737; Carlson, N. R. (2017). Physiology of behavior. Pearson Education.; Chai, X. J., Castañán, A. N., Öngür, D., & Whitfield-Gabrieli, S. (2012). Anticorrelations in resting state networks without global signal regression. NeuroImage, 59(2), 1420-1428. https://doi.org/10.1016/j.neuroimage.2011.08.048; Chaudhuri, K. R., Odin, P., Ferreira, J. J., Antonini, A., Rascol, O., Kurtis, M. M., Storch, A., Bannister, K., Soares-da-Silva, P., Costa, R., Magalhães, D., & Rocha, J. F. (2022). Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial. BMC Neurology, 22(1), 88. https://doi.org/10.1186/s12883-022-02602-8; Chen, H., O’Reilly, E., McCullough, M. L., Rodriguez, C., Schwarzschild, M. A., Calle, E. E., Thun, M. J., & Ascherio, A. (2007). Consumption of dairy products and risk of parkinson’s disease. American Journal of Epidemiology, 165(9), 998-1006. https://doi.org/10.1093/aje/kwk089; Chen, J., Guan, Z., Wang, L., Song, G., Ma, B., & Wang, Y. (2014). Meta-analysis: Overweight, obesity, and Parkinson’s disease. International Journal of Endocrinology,2014, 203930. https://doi.org/10.1155/2014/203930; Chen, J., Zhang, C., Wu, Y., & Zhang, D. (2019). Association between Hypertension and the Risk of Parkinson’s Disease: A Meta-Analysis of Analytical Studies. Neuroepidemiology, 52(3-4), 181-192. https://doi.org/10.1159/000496977; Clark, J. P., Adams, S. G., Dykstra, A. D., Moodie, S., & Jog, M. (2014). Loudness perception and speech intensity control in Parkinson’s disease. Journal of Communication Disorders, 51, 1–12. https://doi.org/10.1016/j.jcomdis.2014.08.001; Clarke CE, Patel S, Ives N, et al. (2016). Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB). Southampton (UK): NIHR Journals Library. (Health Technology Assessment, No. 20.63.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK379760/ doi:10.3310/hta20630.; Cófreces, P., Ofman, S. D., Estay, J. A., & Hermida, P. D. (2022). Enfermedad de Parkinson: una actualización bibliográfica de los aspectos psicosociales. Revista de La Facultad de Ciencias Médicas de Córdoba, 79(2), 181-187. https://doi.org/10.31053/1853.0605.v79.n2.33610; Conte, A., Khan, N., Defazio, G., Rothwell, J. C., & Berardelli, A. (2013). Pathophysiology of somatosensory abnormalities in Parkinson disease. Nature Reviews Neurology, 9(12), 687–697. https://doi.org/10.1038/nrneurol.2013.224; Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ. (2010). The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology, 9, 75(19),1717-25. doi:10.1212/WNL.0b013e3181fc29c9.; Darainy, M., Vahdat, S., & Ostry, D. J. (2019). Neural Basis of Sensorimotor Plasticity in Speech Motor Adaptation. Cerebral Cortex, 29(7), 2876-2889. https://doi.org/10.1093/cercor/bhy153; Dashtipour, K., Tafreshi, A., Lee, J., & Crawley, B. (2018). Speech disorders in Parkinson’s disease: pathophysiology, medical management and surgical approaches. Neurodegenerative disease management 8(5), 337–348. https://doi.org/10.2217/nmt-2018-0021; Dauer, W., Przedborski, S., Schulz, J. B., & Falkenburger, B. H. (2003). Parkinson’s disease: mechanisms and models\rNeuronal pathology in Parkinson’s disease. Neuron, 39(6), 889–909.; De Keyser, K., Santens, P., Bockstael, A., Botteldooren, D., Talsma, D., De Vos, S., Van Cauwenberghe, M., Verheugen, F., Corthals, P., & De Letter, M. (2016). The relationship between speech production and speech perception deficits in Parkinson’s disease. Journal of Speech, Language, and Hearing Research, 59(5), 915–931. https://doi.org/10.1044/2016_JSLHR-S-15-0197; De Lau, L. M. L., Giesbergen, P. C. L. M., De Rijk, M. C., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2004). Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study. Neurology, 63(7), 1240-1244. https://doi.org/10.1212/01.WNL.0000140706.52798.BE; Delic, V., Beck, K. D., Pang, K. C. H., & Citron, B. A. (2020). Biological links between traumatic brain injury and Parkinson’s disease. Acta Neuropathologica Communications, 8(1), 45. https://doi.org/10.1186/s40478-020-00924-7; Despotović I, Goossens B, Philips W. (2015). MRI segmentation of the human brain: challenges, methods, and applications. Computational and Mathematical Methods in Medicine, 450341. doi:10.1155/2015/450341.; Dromey, C., & Adams, S. (2000). Loudness perception and hypophonia in Parkinson disease. Journal of Medical Speech-Language Pathology, 8(4), 255–259.; Dykstra, A. D., Adams, S. G., & Jog, M. (2012). Examining the conversational speech intelligibility of individuals with hypophonia associated with Parkinson’s disease. Journal of Medical Speech-Language Pathology, 20(4), 53.; Elangovan, N., Tuite, P. J., & Konczak, J. (2018). Somatosensory Training Improves Proprioception and Untrained Motor Function in Parkinson’s Disease. Frontiers in Neurology, 9, 1053. https://doi.org/10.3389/fneur.2018.01053; Elfmarková, N., Gajdoš, M., Mračková, M., Mekyska, J., Mikl, M., & Rektorová, I. (2016). Impact of Parkinson’s disease and levodopa on resting state functional connectivity related to speech prosody control. Parkinsonism and Related Disorders, 22(Suppl 1), S52-5. https://doi.org/10.1016/j.parkreldis.2015.09.006; Erekat, N. S. (2022). Autophagy and Its Association with Genetic Mutations in Parkinson Disease. Medical Science Monitor, 28, e938519. https://doi.org/10.12659/MSM.938519; Espay, A. J., Pagan, F. L., Walter, B. L., Morgan, J. C., Elmer, L. W., Waters, C. H., Agarwal, P., Dhall, R., Ondo, W. G., Klos, K. J., & Silver, D. E. (2017). Optimizing extended-release carbidopa/levodopa in Parkinson disease. Neurology: Clinical Practice, 7(1), 86-93. https://doi.org/10.1212/CPJ.0000000000000316; Espay, A. J., Stocchi, F., Pahwa, R., Albanese, A., Ellenbogen, A., Ferreira, J. J., Giladi, N., Gurevich, T., Hassin-Baer, S., Hernandez-Vara, J., Isaacson, S. H., Kieburtz, K., LeWitt, P. A., Lopez-Manzanares, L., Olanow, C. W., Poewe, W., Sarva, H., Yardeni, T., Adar, L., … Zhukova, I. (2024). Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson’s disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial. The Lancet Neurology, 23(5), 465-476. https://doi.org/10.1016/S1474-4422(24)00052-8; Fabbri, M., Guimarães, I., Cardoso, R., Coelho, M., Guedes, L. C., Rosa, M. M., Godinho, C., Abreu, D., Gonçalves, N., Antonini, A., & Ferreira, J. J. (2017). Speech and voice response to a levodopa challenge in late-stage Parkinson’s disease. Frontiers in Neurology, 8, 432. https://doi.org/10.3389/fneur.2017.00432; Fahn, S., & Elton, R. L. (1987). UPDRS DEVELOPMENT COMMITTEE. Unified Parkinson’s Disease Rating Scale. Recent developments in Parkinson’s disease, 2, 153–163, 293–304.; Fernández-Santiago, R., & Sharma, M. (2022). What have we learned from genome-wide association studies (GWAS) in Parkinson’s disease? Ageing Research Reviews,79, 101648. https://doi.org/10.1016/j.arr.2022.101648; Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kanovsky, P., Kostic, V., Nieuwboer, A., Odin, P., Poewe, W., Rascol, O., Sampaio, C., Schüpbach, M., Tolosa, E., Trenkwalder, C., … Oertel, W. H. (2013). Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson’s disease. European Journal of Neurology, 20(1), 5-15. https://doi.org/10.1111/j.1468-1331.2012.03866.x; Fox, C. M., Morrison, C. E., Ramig, L. O., & Sapir, S. (2002). Current perspectives on the Lee Silverman voice treatment (LSVT) for individuals with idiopathic Parkinson disease. American Journal of Speech-Language Pathology, 11(2), 111-123. https://doi.org/10.1044/1058-0360(2002/012); Friston, K. J., Ashburner, J., Frith, C. D., Poline, J. ‐B, Heather, J. D., & Frackowiak, R. S. J. (1995). Spatial registration and normalization of images. Human Brain Mapping, 3(3) 165-189. https://doi.org/10.1002/hbm.460030303; Friston, K. J., Williams, S., Howard, R., Frackowiak, R. S. J., & Turner, R. (1996). Movement-related effects in fMRI time-series. Magnetic Resonance in Medicine, 35(3) 346-355. https://doi.org/10.1002/mrm.1910350312; Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015). Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease. Autophagy,11(9) 1443-1457. https://doi.org/10.1080/15548627.2015.1067364; Goetz, C. G., Fahn, S., Martinez-Martin, P., Poewe, W., Sampaio, C., Stebbins, G. T., Stern, M. B., Tilley, B. C., Dodel, R., Dubois, B., Holloway, R., Jankovic, J., Kulisevsky, J., Lang, A. E., Lees, A., Leurgans, S., LeWitt, P. A., Nyenhuis, D., Olanow, C. W., … LaPelle, N. (2007). Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders, 22(1), 41–47. https://doi.org/10.1002/mds.21198; Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez-Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., Dubois, B., Holloway, R., Jankovic, J., Kulisevsky, J., Lang, A. E., Lees, A., Leurgans, S., LeWitt, P. A., Nyenhuis, D., … Zweig, R. M. (2008). Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129–2170. https://doi.org/10.1002/mds.22340; Gong, S., Xu, M., Tao, Y., Jin, H., Liu, Y., Sun, X., Wang, S., Yang, X., Wang, Y., Yuan, L., & Song, W. (2020). Comparison of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation Surgery on Parkinson Disease–Related Pain. World Neurosurgery, 135, e94-e99. https://doi.org/10.1016/j.wneu.2019.11.026; Haas, B. M., Trew, M., & Castle, P. C. (2004). Effects of respiratory muscle weakness on daily living function, quality of life, activity levels, and exercise capacity in mild to moderate Parkinson’s disease. American Journal of Physical Medicine and Rehabilitation, 83(8), 601-607. https://doi.org/10.1097/01.PHM.0000133436.61009.02; Hallquist, M. N., Hwang, K., & Luna, B. (2013). The nuisance of nuisance regression: Spectral misspecification in a common approach to resting-state fMRI preprocessing reintroduces noise and obscures functional connectivity. NeuroImage, 82, 208-225. https://doi.org/10.1016/j.neuroimage.2013.05.116; Hariz, M., Lees, A. J., Blomstedt, Y., & Blomstedt, P. (2022). Serendipity and Observations in Functional Neurosurgery: From James Parkinson’s Stroke to Hamani’s & Lozano’s Flashbacks. Stereotactic and Functional Neurosurgery,100(4), 201-209. https://doi.org/10.1159/000525794; Hayes, M. T. (2019). Parkinson’s Disease and Parkinsonism. American Journal of Medicine, 132(7), 802–807. https://doi.org/10.1016/j.amjmed.2019.03.001; Henchcliffe, C., & Beal, F. M. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature Clinical Practice Neurology,4(11), 600-609. https://doi.org/10.1038/ncpneuro0924; Hickok, G. (2014). The architecture of speech production and the role of the phoneme in speech processing. Language, Cognition and Neuroscience, 29(1), 2–20. https://doi.org/10.1080/01690965.2013.834370; Hirano, M. (1981). Psycho-acoustic evaluation of voice: GRBAS scale for evaluating the hoarse voice. Clinical examination of voice.; Hlavnika, J., Cmejla, R., Tykalová, T., Šonka, K., Ruzicka, E., & Rusz, J. (2017). Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder. Scientific Reports, 7(1), 12. https://doi.org/10.1038/s41598-017-00047-5; Ho, A. K., Bradshaw, J. L., & Iansek, R. (2000). Volume perception in Parkinsonian speech. Movement Disorders, 15(6), 1125–1131. https://doi.org/10.1002/1531-8257(200011)15:63.0.CO;2-R; Ho, A. K., Bradshaw, J. L., & Iansek, R. (2008). For better or worse: The effect of Levodopa on speech in Parkinson’s disease. Movement Disorders, 23(4), 574–580. https://doi.org/10.1002/mds.21899; Ho, A. K., Bradshaw, J. L., Iansek, R., & Alfredson, R. (1999). Speech volume regulation in Parkinson’s disease: Effects of implicit cues and explicit instructions. Neuropsychologia, 37(13), 1453-1460. https://doi.org/10.1016/S0028-3932(99)00067-6; Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17(5), 427-442. https://doi.org/10.1212/wnl.17.5.427; Hong, C. T., Chan, L., & Bai, C. H. (2020). The effect of caffeine on the risk and progression of Parkinson’s disease: A meta-analysis. Nutrients, 12(6), 1860. https://doi.org/10.3390/nu12061860; Houde, J. F., & Nagarajan, S. S. (2011). Speech production as state feedback control. Frontiers in Human Neuroscience, 5(82), 1-14. https://doi.org/10.3389/fnhum.2011.00082; Huang, X., Chen, X., Yan, N., Jones, J. A., Wang, E. Q., Chen, L., Guo, Z., Li, W., Liu, P., & Liu, H. (2016). The impact of Parkinson’s disease on the cortical mechanisms that support auditory–motor integration for voice control. Human Brain Mapping, 37(12), 4248–4261. https://doi.org/10.1002/hbm.23306; Hubsher, G., Haider, M., & Okun, M. S. (2012). Amantadine: The journey from fighting flu to treating Parkinson disease. Neurology, 78(14), 1096-1099. https://doi.org/10.1212/WNL.0b013e31824e8f0d; Im, H., Adams, S., Abeysekera, A., Pieterman, M., Gilmore, G., & Jog, M. (2019). Effect of Levodopa on Speech Dysfluency in Parkinson’s Disease. Movement Disorders Clinical Practice, 6(2), 150–154. https://doi.org/10.1002/mdc3.12714; Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson’s disease questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score. Age and Ageing, 26(5), 353-357. https://doi.org/10.1093/ageing/26.5.353; Karine, R., Luc, N. J., & Nadine, V. (2010). The effect of levodopa on speech in Parkinson’s disease: Musical’ scale study. Proceedings of the International Conference on Speech Prosody, 1-4. https://doi.org/10.21437/speechprosody.2010-244; Kaut, O., Schmitt, I., Stahl, F., Fröhlich, H., Hoffmann, P., Gonzalez, F. J., & Wüllner, U. (2022). Epigenome-Wide Analysis of DNA Methylation in Parkinson’s Disease Cortex. Life, 12(4), 502. https://doi.org/10.3390/life12040502; Kempster, G. B., Gerratt, B. R., Abbott, K. V., Barkmeier-Kraemer, J., & Hillman, R. E. (2009). Consensus auditory-perceptual evaluation of voice: Development of a standardized clinical protocol. American Journal of Speech-Language Pathology, 18(2), 124–132. https://doi.org/10.1044/1058-0360(2008/08-0017); Keus, S. H. J., Munneke, M., Nijkrake, M. J., Kwakkel, G., & Bloem, B. R. (2009). Physical therapy in Parkinson’s disease: Evolution and future challenges. Movement Disorders, 24(1), 1-14. https://doi.org/10.1002/mds.22141; Kim, J. J., Vitale, D., Veliz-Otani, D., Lian, M., Heilbron, K., Team, the 23andMe R., Iwaki, H., Lake, J., Solsberg, C. W., Leonard, H., Makarious, M. B., Tan, E.-K., Singleton, A. B., Bandres-Ciga, S., Noyce, A. J., Blauwendraat, C., Nalls, M. A., Foo, J. N., & Mata, I. (2024). Multi-ancestry genome-wide meta-analysis in Parkinson’s disease. Nature Genetics, 56(1), 27-36.; Kim, K. S., Gaines, J. L., Parrell, B., Ramanarayanan, V., Nagarajan, S. S., & Houde, J. F. (2023). Mechanisms of sensorimotor adaptation in a hierarchical state feedback control model of speech. PLoS Computational Biology, 19(7), e1011244. https://doi.org/10.1371/journal.pcbi.1011244; Knight, E. J., Testini, P., Min, H. K., Gibson, W. S., Gorny, K. R., Favazza, C. P., Felmlee, J. P., Kim, I., Welker, K. M., Clayton, D. A., Klassen, B. T., Chang, S. Y., & Lee, K. H. (2015). Motor and nonmotor circuitry activation induced by subthalamic nucleus deep brain stimulation in patients with Parkinson disease: Intraoperative functional magnetic resonance imaging for deep brain stimulation. Mayo Clinic Proceedings, 90(6), 773-785. https://doi.org/10.1016/j.mayocp.2015.03.022; Kobayashi, S., Maki, T., & Kunimoto, M. (2011). Clinical symptoms of bilateral anterior cerebral artery territory infarction. Journal of Clinical Neuroscience, 18(2), 218-222. https://doi.org/10.1016/j.jocn.2010.05.013; Kolb, B., & Whishaw, I. (2014). An Introduction to Brain and Behavior (4th ed.). Worth Publishers.; Konczak, J., Corcos, D. M., Horak, F., Poizner, H., Shapiro, M., Tuite, P., Volkmann, J., & Maschke, M. (2009). Proprioception and Motor Control in Parkinson’s Disease. Journal of Motor Behavior, 41(6), 543–552. https://doi.org/10.3200/35-09-002; Kreiman, J., & Gerratt, B. R. (2000). Sources of listener disagreement in voice quality assessment. The Journal of the Acoustical Society of America, 108(4), 1867-1876. https://doi.org/10.1121/1.1289362; Lechien, J. R., Delsaut, B., Abderrakib, A., Huet, K., Delvaux, V., Piccaluga, M., Khalife, M., Harmegnies, B., Saussez, S., & Blecic, S. (2020). Orofacial Strength and Voice Quality as Outcome of Levodopa Challenge Test in Parkinson Disease. Laryngoscope, 130(12), E896-E903. https://doi.org/10.1002/lary.28645; Lees, A. J., Hardy, J., & Revesz, T. (2009). Parkinson’s disease. The Lancet, 373(9680), 2055–2066. https://doi.org/10.1016/S0140-6736(09)60492-X; Li, S. H., Chen, H. B., Wang, Z. F., Tang, R. H., Zhang, X. Y., Yang, J. S., Zhao, W. Q., Sun, X. R., & Ma, J. (2013). Efficacy and safety of ropinirole in the treatment of Parkinson disease: a multi-center, randomized, double-blind and bromocriptine-controlled trial. National Medical Journal of China, 93(25), 1952-1957. https://doi.org/10.3760/cma.j.issn.0376-2491.2013.25.005; Lieberman, A. N., & Goldstein, M. (1985). Bromocriptine in Parkinson disease. Pharmacological Reviews, 37(2), 217-227. https://doi.org/10.1212/wnl.29.3.363; Lin, M. T., Cantuti-Castelvetri, I., Zheng, K., Jackson, K. E., Tan, Y. B., Arzberger, T., Lees, A. J., Betensky, R. A., Beal, M. F., & Simon, D. K. (2012). Somatic mitochondrial DNA mutations in early Parkinson and incidental lewy body disease. Annals of Neurology, 71(6), 850-854. https://doi.org/10.1002/ana.23568; Lombard, E. (1911). Le signe de l’élévation de la voix (translated from French). Annales Des Maladies de l’oreille et Du Larynx, 37(2), 101-119.; Lukos, J. R., Snider, J., Hernandez, M. E., Tunik, E., Hillyard, S., & Poizner, H. (2013). Parkinson’s disease patients show impaired corrective grasp control and eye-hand coupling when reaching to grasp virtual objects. Neuroscience, 254, 205-221. https://doi.org/10.1016/j.neuroscience.2013.09.026; Manes, J. L., Kurani, A. S., Herschel, E., Roberts, A. C., Tjaden, K., Parrish, T., & Corcos, D. M. (2023). Premotor cortex is hypoactive during sustained vowel production in individuals with Parkinson’s disease and hypophonia. Frontiers in Human Neuroscience, 17, 1250114. https://doi.org/10.3389/fnhum.2023.1250114; Manes, J. L., Parkinson, A. L., Larson, C. R., Greenlee, J. D., Eickhoff, S. B., Corcos, D. M., & Robin, D. A. (2014). Connectivity of the subthalamic nucleus and globus pallidus pars interna to regions within the speech network: A meta-analytic connectivity study. Human Brain Mapping, 35(7), 3499–3516. https://doi.org/10.1002/hbm.22417; Manes, J. L., Tjaden, K., Parrish, T., Simuni, T., Roberts, A., Greenlee, J. D., Corcos, D. M., & Kurani, A. S. (2018). Altered resting-state functional connectivity of the putamen and internal globus pallidus is related to speech impairment in Parkinson’s disease. Brain and Behavior, 8(9), e01073. https://doi.org/10.1002/brb3.1073; Margolesky, J., & Singer, C. (2018). Extended-release oral capsule of carbidopa-levodopa in parkinson disease. Therapeutic Advances in Neurological Disorders, 11, 1756285617737728. https://doi.org/10.1177/1756285617737728; Marín-M, D. S., Carmona-V, H., Ibarra-Q, M., & Gámez-C, M. (2022). Enfermedad de Parkinson: fisiopatología, diagnóstico y tratamiento. Revista de la Universidad Industrial de Santander Salud, 50(1), 79-92.; Marín-Medina, D. S., Quintero-Moreno, J. F., Valencia-Vásquez, A., Duque-Salazar, C., Gil-Restrepo, A. F., Castaño-Montoya, J. P., García-Rodríguez, D., & Carmona-Villada, H. (2018). Deep brain stimulation in parkinson disease. Iatreia, 31(3), 262–273. https://doi.org/10.17533/udea.iatreia.v31n3a04; Martínez-Fernández, R., Gasca-Salas, C., Sánchez-Ferro, Á., & Obeso, J. Á. (2016). Actualización en la enfermedad de Parkinson. Revista Médica Clínica Las Condes, 27(3), 363–379.; Martínez-Fernández, R., Máñez-Miró, J. U., Rodríguez-Rojas, R., del Álamo, M., Shah, B. B., Hernández-Fernández, F., Pineda-Pardo, J. A., Monje, M. H. G., Fernández-Rodríguez, B., Sperling, S. A., Mata-Marín, D., Guida, P., Alonso-Frech, F., Obeso, I., Gasca-Salas, C., Vela-Desojo, L., Elias, W. J., & Obeso, J. A. (2020). Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease. New England Journal of Medicine, 383(26), 2501-2513. https://doi.org/10.1056/nejmoa2016311; Mata-Marín, D., Pineda-Pardo, J. A., Molina, J. A., Vela, L., Alonso-Frech, F., & Obeso, I. (2021). Aberrant Salient and Corticolimbic Connectivity in Hypersexual Parkinson’s Disease. Brain Connectivity, 11(8), 639-650. https://doi.org/10.1089/brain.2020.0868; McDonnell, M. N., Rischbieth, B., Schammer, T. T., Seaforth, C., Shaw, A. J., & Phillips, A. C. (2018). Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson’s disease: a systematic review and meta-analysis. Clinical Rehabilitation, 32(5), 607-618. https://doi.org/10.1177/0269215517734385; Meléndez Flores, J. D., Castillo Torres, S. A., Cerda Contreras, C., Chávez Luévanos, B. E., & Estrada Bellmann, I. (2021). Características clínicas del síndrome metabólico en pacientes con enfermedad de Parkinson. Revista de Neurología, 72(1), 9-15. https://doi.org/10.33588/rn.7201.2020323; Miller, N., Noble, E., Jones, D., & Burn, D. (2006). Life with communication changes in Parkinson’s disease. Age and Ageing, 35(3), 235–239. https://doi.org/10.1093/ageing/afj053; Morato-Galán, M. (2014). Análisis perceptual de la disfonía: adaptación y validación del método CAPE-V al español. Universidad de Oviedo.; Moreau, C., & Pinto, S. (2019). Misconceptions about speech impairment in Parkinson’s disease. Movement Disorders, 34(10), 1471–1475. https://doi.org/10.1002/mds.27791; Nagaratnam, N., Nagaratnam, K., Ng, K., & Diu, P. (2004). Akinetic mutism following stroke. Journal of Clinical Neuroscience, 11(1), 25-30. https://doi.org/10.1016/j.jocn.2003.04.002; Nagle, K. F. (2022). Clinical Use of the CAPE-V Scales: Agreement, Reliability and Notes on Voice Quality. Journal of Voice, S08921997(22), 00366-6. https://doi.org/10.1016/j.jvoice.2022.11.014; Nakamura, M., Hamamoto, M., Uchida, S., Nagayama, H., Amemiya, S., Okubo, S., & Tanaka, K. (2003). A case of micrographia after subcortical infarction: Possible involvement of frontal lobe function. European Journal of Neurology, 10(5), 593-596. https://doi.org/10.1046/j.1468-1331.2003.00641.x; Narea-Veas, M. S., Farías, P. G., & Vázquez Fernández, P. (2023). Consensus Auditory Perceptual Evaluation of Voice (CAPE-V): Systematic Review of Methods Used for Adaptation and Validation. Revista de Investigacion e Innovacion en Ciencias de la Salud, 5(2), 178-204. https://doi.org/10.46634/riics.206; Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x; New, A. B., Robin, D. A., Parkinson, A. L., Eickhoff, C. R., Reetz, K., Hoffstaedter, F., Mathys, C., Sudmeyer, M., Grefkes, C., Larson, C. R., Ramig, L. O., Fox, P. T., & Eickhoff, S. B. (2015). The intrinsic resting state voice network in Parkinson’s disease. Human Brain Mapping, 36(5), 1951–1962. https://doi.org/10.1002/hbm.22748; Nieto-Castanon, A. (2020). Handbook of functional connectivity Magnetic Resonance Imaging methods in CONN. Hilbert-Press. https://doi.org/10.56441/hilbertpress.2207.6598; Niziolek, C. A., & Guenther, F. H. (2013). Vowel category boundaries enhance cortical and behavioral responses to speech feedback alterations. Journal of Neuroscience, 33(29), 12090–12098. https://doi.org/10.1523/JNEUROSCI.1008-13.2013; Núñez-Batalla, F., Morato-Galán, M., García-López, I., & Ávila-Menéndez, A. (2015). Adaptación fonética y validación del método de valoración perceptual de la voz CAPE-V al español. Acta Otorrinolaringologica Espanola, 66(5), 249–257. https://doi.org/10.1016/j.otorri.2014.07.007; Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2008). The basal ganglia in Parkinson’s disease: Current concepts and unexplained observations. Annals of Neurology, 64(2), S30-46. https://doi.org/10.1002/ana.21481; Obeso, J. A., Rodríguez-Oroz, M. C., Benitez-Temino, B., Blesa, F. J., Guridi, J., Marin, C., & Rodriguez, M. (2008). Functional organization of the basal ganglia: Therapeutic implications for Parkinson’s disease. Movement Disorders, 23(Suppl. 3), S548-559. https://doi.org/10.1002/mds.22062; Ohtomo, R., Iwata, A., & Tsuji, S. (2014). Unilateral opercular infarction presenting with foix-chavany-marie syndrome. Journal of Stroke and Cerebrovascular Diseases, 23(1), 179-181. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.08.015; Paccosi, E., & Proietti-De-Santis, L. (2023). Parkinson’s Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy. International Journal of Molecular Sciences,24(11), 9547. https://doi.org/10.3390/ijms24119547; Panza, F., Lozupone, M., Sardone, R., Battista, P., Piccininni, M., Dibello, V., La Montagna, M., Stallone, R., Venezia, P., Liguori, A., Giannelli, G., Bellomo, A., Greco, A., Daniele, A., Seripa, D., Quaranta, N., & Logroscino, G. (2019). Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life. Therapeutic Advances in Chronic Disease, 10, 1–17. https://doi.org/10.1177/2040622318811000; Pedraza, O. L., Salazar, A. M., Sierra, F. A., Soler, D., Castro, J., Castillo, P. C., Hernandez, M. A., & Piñeros, C. (2017). Confiabilidad, validez de criterio y discriminante del Montreal Cognitive Assessment (MoCA) test, en un grupo de Adultos de Bogotá. Acta Médica Colombiana, 41(4), 221–228. https://doi.org/10.36104/amc.2016.693; Phokaewvarangkul, O., Boonpang, K., & Bhidayasiri, R. (2019). Subthalamic deep brain stimulation aggravates speech problems in Parkinson’s disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location. Parkinsonism and Related Disorders, 66(April), 110–116. https://doi.org/10.1016/j.parkreldis.2019.07.020; Pihlstrøm, L., Shireby, G., Geut, H., Henriksen, S. P., Rozemuller, A. J. M., Tunold, J. A., Hannon, E., Francis, P., Thomas, A. J., Love, S., Mill, J., van de Berg, W. D. J., & Toft, M. (2022). Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology. Nature Communications, 13(1), 4932. https://doi.org/10.1038/s41467-022-32619-z; Pinel, J. P. J., & Barnes, S. (2021). Biopsychology (10th Edition). Pearson Education.; Pinho, S. R., & Pontes, P. (2002). Escala de evaluación perceptiva de la fuente glótica: RASAT. Vox Brasilis, 8(3), 1-4.; Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-Dowsey, P., & Auzou, P. (2004). Treatments for dysarthria in Parkinson’s disease. Lancet Neurology, 3(9), 547–556. https://doi.org/10.1016/S1474-4422(04)00854-3; Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A. E., & Lang, A. E. (2017). Parkinson disease. Nature Reviews Disease Primers, 3, 17013.; Portet, F., Ousset, P. J., Visser, P. J., Frisoni, G. B., Nobili, F., Scheltens, P., Vellas, B., & Touchon, J. (2006). Mild cognitive impairment (MCI) in medical practice: A critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. Journal of Neurology, Neurosurgery and Psychiatry, 77(6), 714-718. https://doi.org/10.1136/jnnp.2005.085332; Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. (2015). MDS clinical diagnostic criteria for Parkinsons disease. Movement Disorders, 30(12), 1591-601. doi:10.1002/mds.26424. PMID: 26474316.; Power, J. D., Mitra, A., Laumann, T. O., Snyder, A. Z., Schlaggar, B. L., & Petersen, S. E. (2014). Methods to detect, characterize, and remove motion artifact in resting state fMRI. NeuroImage, 84, 320–341. https://doi.org/10.1016/j.neuroimage.2013.08.048; Railo, H., Nokelainen, N., Savolainen, S., & Kaasinen, V. (2020). Deficits in monitoring self-produced speech in Parkinson’s disease. Clinical Neurophysiology, 131(9), 2140–2147. https://doi.org/10.1016/j.clinph.2020.05.038; Ramig, L., Fox, C., & Sapir, S. (2008). Speech treatment for Parkinson’s disease. Expert Review of Neurotherapeutics, 8(2), 299–311. https://doi.org/10.1586/14737175.8.2.297; Ray Dorsey, E., Elbaz, A., Nichols, E., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J. Y. J., Collado-Mateo, D., Dahodwala, N., Do, H. P., Edessa, D., Endres, M., Fereshtehnejad, S. M., Foreman, K. J., Gankpe, F. G., Gupta, R., Hankey, G. J., … Murray, C. J. L. (2018). Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(11), 939-953. https://doi.org/10.1016/S1474-4422(18)30295-3; Ray, M., Dening, T., & Crosbie, B. (2019). Dementia and hearing loss: A narrative review. Maturitas, 128, 64–69. https://doi.org/10.1016/j.maturitas.2019.08.001; Rektorova, I., Barrett, J., Mikl, M., Rektor, I., & Paus, T. (2007). Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson’s disease. Movement Disorders, 22(14), 2043–2051. https://doi.org/10.1002/mds.21548; Rektorova, I., Mikl, M., Barrett, J., Marecek, R., Rektor, I., & Paus, T. (2012). Functional neuroanatomy of vocalization in patients with Parkinson’s disease. Journal of the Neurological Sciences, 313(1–2), 7–12. https://doi.org/10.1016/j.jns.2011.10.020; Rhonda, J. H., Oates, J. M., Debbie, J. P., & Andrew, J. H. (2000). Voice characteristics in the progression of Parkinson’s disease. International Journal of Language and Communication Disorders, 35(3), 407-418. https://doi.org/10.1080/136828200410654; Ricci-Maccarini, A., Schindler, A., Mozzanica, F., Fantini, M., Murry, T., & Dejonckere, P. (2022, en prensa). Validity, Reliability and Reproducibility of the “Extended GRBAS Scale,” A Comprehensive Perceptual Evaluation of Dysphonia. Journal of Voice. https://doi.org/10.1016/j.jvoice.2022.09.008; Riederer, P., & Müller, T. (2018). Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects. Journal of Neural Transmission, 125(11), 1751-1757. https://doi.org/10.1007/s00702-018-1876-2; Rizek, P., Kumar, N., & Jog, M. S. (2016). An update on the diagnosis and treatment of Parkinson disease. CMAJ, 188(16), 1157-1165. https://doi.org/10.1503/cmaj.151179; Rodríguez-López, C., Ayuso García, B., & Moreno García, S. (2018). Hypophonia as a sign of thalamus lesion: a case report. International Journal of Neuroscience, 128(1), 100–101. https://doi.org/10.1080/00207454.2017.1358716; Rodriguez-Sabate, C., Morales, I., Lorenzo, J. N., & Rodriguez, M. (2019). The organization of the basal ganglia functional connectivity network is non-linear in Parkinson’s disease. NeuroImage: Clinical, 22, 101708. https://doi.org/10.1016/j.nicl.2019.101708; Rosqvist, K., Horne, M., Hagell, P., Iwarsson, S., Nilsson, M. H., & Odin, P. (2018). Levodopa effect and motor function in late stage Parkinson’s disease. Journal of Parkinson’s Disease, 8(1), 59–70. https://doi.org/10.3233/JPD-171181; Rughani, A., Schwalb, J. M., Sidiropoulos, C., Pilitsis, J., Ramirez-Zamora, A., Sweet, J. A., Mittal, S., Espay, A. J., Martinez, J. G., Abosch, A., Eskandar, E., Gross, R., Alterman, R., & Hamani, C. (2018). Congress of neurological surgeons systematic review and evidence-based guideline on subthalamic nucleus and globus pallidus internus deep brain stimulation for the treatment of patients with Parkinson’s disease: Executive summary. Neurosurgery, 82(6), 753-756. https://doi.org/10.1093/neuros/nyy037; Sadagopan, N., & Huber, J. E. (2007). Effects of loudness cues on respiration in individuals with Parkinson’s disease. Movement Disorders, 22(5), 651-659. https://doi.org/10.1002/mds.21375; Sapir, S., Ramig, L. O., & Fox, C. M. (2011). Intensive voice treatment in Parkinson’s disease: Lee Silverman Voice Treatment. Expert Review of Neurotherapeutics, 11(6), 815-830. https://doi.org/10.1586/ern.11.43; Scarpa, A., Cassandro, C., Vitale, C., Ralli, M., Policastro, A., Barone, P., Cassandro, E., & Pellecchia, M. T. (2020). A comparison of auditory and vestibular dysfunction in Parkinson’s disease and Multiple System Atrophy. Parkinsonism and Related Disorders, 71, 51–57. https://doi.org/10.1016/j.parkreldis.2020.01.018; Schneider, J. S., Diamond, S. G., & Markham, C. H. (1986). Deficits in orofacial sensorimotor function in Parkinson’s disease. Annals of Neurology, 19(3), 275-282. https://doi.org/10.1002/ana.410190309; Scott, R., Gregory, R., Hines, N., Carroll, C., Hyman, N., Papanasstasiou, V., Leather, C., Rowe, J., Silburn, P., & Aziz, T. (1998). Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson’s disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain, 121(4), 659-675. https://doi.org/10.1093/brain/121.4.659; Senthinathan, A., Adams, S., Page, A. D., & Jog, M. (2021). Speech intensity response to altered intensity feedback in individuals with Parkinson’s disease. Journal of Speech, Language, and Hearing Research, 64(6s), 2261-2275. https://doi.org/10.1044/2021_JSLHR-20-00278; Simon, D. K., Tanner, C. M., & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine, 36(1), 1–12. https://doi.org/10.1016/j.cger.2019.08.002; Smith, K. M., & Caplan, D. N. (2018). Communication impairment in Parkinson’s disease: Impact of motor and cognitive symptoms on speech and language. Brain and Language, 185(July), 38–46. https://doi.org/10.1016/j.bandl.2018.08.002; Smith, L. J., Lee, C. Y., Menozzi, E., & Schapira, A. H. V. (2022). Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease. Frontiers in Neurology, 13, 971252. https://doi.org/10.3389/fneur.2022.971252; Solomon, N. P., & Hixon, T. J. (1993). Speech breathing in Parkinson’s disease. Journal of Speech and Hearing Research, 36(2) 294-310. https://doi.org/10.1044/jshr.3602.294; Sonkaya, Z. Z., Ceylan, M., & Sonkaya, A. R. (2021). Speech characteristics of parkinson disease. Medical Science and Discovery, 8(12), 666-670. https://doi.org/10.36472/msd.v8i12.645; Stathopoulos, E. T., Huber, J. E., Richardson, K., Kamphaus, J., DeCicco, D., Darling, M., Fulcher, K., & Sussman, J. E. (2014). Increased vocal intensity due to the Lombard effect in speakers with Parkinson’s disease: Simultaneous laryngeal and respiratory strategies. Journal of Communication Disorders, 48(1), 1–17. https://doi.org/10.1016/j.jcomdis.2013.12.001; Stathopoulos, E. T., & Sapienza, C. M. (1997). Developmental changes in laryngeal and respiratory function with variations in sound pressure level. Journal of Speech, Language, and Hearing Research, 40(3), 595-614. https://doi.org/10.1044/jslhr.4003.595; Strickland, D. (2012). Rural environment and Parkinson’s disease. En R. F. Pfeiffer, Z. K. Wszolek & M. Ebadi (Eds.) Parkinson’s Disease (2nd Edition) (pp. 63–71). CRC Press. https://doi.org/10.1201/b12948; Suárez Torres, M., Cano Villagrasa, A., & Valles González, B. (2020). Diagnósticos Fonoaudiológicos y Síntomas no Motores en Pacientes con Enfermedad de Parkinson. Areté, 20(2), 63-71. https://doi.org/10.33881/1657-2513.art20207; Thacker, E. L., O’Reilly, E. J., Weisskopf, M. G., Chen, H., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2007). Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology, 68(10), 764-768. https://doi.org/10.1212/01.wnl.0000256374.50227.4b; Tiwari, P. C., & Pal, R. (2017). The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialogues in Clinical Neuroscience, 19(1), 71-80. https://doi.org/10.31887/dcns.2017.19.1/rpal; Tsalenchuk, M., Gentleman, S. M., & Marzi, S. J. (2023). Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease. NPJ Parkinson’s Disease, 9(1), 123. https://doi.org/10.1038/s41531-023-00568-z; Tursunov, D. (2020). L-Dopa induced dyskinesia. Parkinsonism & Related Disorders, 79, e94. https://doi.org/10.1016/j.parkreldis.2020.06.342; Ulla, M., Bonny, J. M., Ouchchane, L., Rieu, I., Claise, B., & Durif, F. (2013). Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up. PLoS ONE, 8(3), e57904. https://doi.org/10.1371/journal.pone.0057904; Ullah, I., Zhao, L., Hai, Y., Fahim, M., Alwayli, D., Wang, X., & Li, H. (2021). “Metal elements and pesticides as risk factors for Parkinson’s disease - A review.” Toxicology Reports, 8, 607-616. https://doi.org/10.1016/j.toxrep.2021.03.009; Van Den Eeden, S. K., Tanner, C. M., Bernstein, A. L., Fross, R. D., Leimpeter, A., Bloch, D. A., & Nelson, L. M. (2003). Incidence of Parkinson’s disease: Variation by age, gender, and race/ethnicity. American Journal of Epidemiology, 157(11) 1015-1022. https://doi.org/10.1093/aje/kwg068; Vara, A. C., Medeiros, R., & Striebel, V. L. W. (2012). Physical therapy in parkinson’s disease. Revista Neurociencias, 20(2), 266–272. https://doi.org/10.34024/rnc.2012.v20.8281; Venezia, J. H., Fillmore, P., Matchin, W., Lisette Isenberg, A., Hickok, G., & Fridriksson, J. (2016). Perception drives production across sensory modalities: A network for sensorimotor integration of visual speech. NeuroImage, 126, 196–207. https://doi.org/10.1016/j.neuroimage.2015.11.038; Vitale, C., Marcelli, V., Abate, T., Pianese, A., Allocca, R., Moccia, M., Spina, E., Barone, P., Santangelo, G., & Cavaliere, M. (2016). Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson’s disease. Parkinsonism and Related Disorders, 22(Suppl 1), S138–S143. https://doi.org/10.1016/j.parkreldis.2015.09.040; Walker, G. M., & Hickok, G. (2016). Bridging computational approaches to speech production: The semantic–lexical–auditory–motor model (SLAM). Psychonomic Bulletin and Review, 23(2), 339–352. https://doi.org/10.3758/s13423-015-0903-7; Walshe, M., & Miller, N. (2011). Living with acquired dysarthria: The speaker’s perspective. Disability and Rehabilitation, 33(3), 195–203. https://doi.org/10.3109/09638288.2010.511685; Yang, W., Liu, B., Huang, B., Huang, R., Wang, L., Zhang, Y., Zhang, X., & Wu, K. (2016). Altered resting-state functional connectivity of the striatum in Parkinson’s disease after levodopa administration. PLoS ONE, 11(9), e0161935. https://doi.org/10.1371/journal.pone.0161935; Yin, H. H. (2017). The Basal Ganglia in Action. Neuroscientist, 23(3), 299-313. https://doi.org/10.1177/1073858416654115; Yu, Q. W., Ye, T. F., & Qian, W. J. (2021). Rare coexistence of multiple manifestations secondary to thalamic hemorrhage: A case report. World Journal of Clinical Cases, 9(18), 4817-4822. https://doi.org/10.12998/wjcc.v9.i18.4817; Yuan, F., Guo, X., Wei, X., Xie, F., Zheng, J., Huang, Y., Huang, Z., Chang, Z., Li, H., Guo, Y., Chen, J., Guo, J., Tang, B., Deng, B., & Wang, Q. (2020). Lee Silverman Voice Treatment for dysarthria in patients with Parkinson’s disease: a systematic review and meta-analysis. European Journal of Neurology, 27(10), 1957-1970. https://doi.org/10.1111/ene.14399; Zarzur, A. P., Duprat, A. C., Shinzato, G., & Eckley, C. A. (2007). Laryngeal electromyography in adults with Parkinson’s disease and voice complaints. Laryngoscope, 117(5), 831-834. https://doi.org/10.1097/MLG.0b013e3180333145; Zegleń, M., Sladowska, K., Kawalec, P., & Brzostek, T. (2022). Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson’s disease: a systematic review and meta-analysis. Journal of Comparative Effectiveness Research, 11(12), 889-904. https://doi.org/10.2217/cer-2022-0031; Zeighami, Y., Ulla, M., Iturria-Medina, Y., Dadar, M., Zhang, Y., Larcher, K. M. H., Fonov, V., Evans, A. C., Collins, D. L., & Dagher, A. (2015). Network structure of brain atrophy in de novo Parkinson’s disease. ELife, 4, e08440. https://doi.org/10.7554/eLife.08440; Zhang, K., Paul, K. C., Jacobs, J. P., Chou, H. C. (Lori), Duarte Folle, A., Del Rosario, I., Yu, Y., Bronstein, J. M., Keener, A. M., & Ritz, B. (2022). Parkinson’s Disease and the Gut Microbiome in Rural California. Journal of Parkinson’s Disease, 12(8), 2441-2452. https://doi.org/10.3233/JPD-223500; https://hdl.handle.net/1992/74621; instname:Universidad de los Andes; reponame:Repositorio Institucional Séneca; repourl:https://repositorio.uniandes.edu.co/

  2. 2
    Book
  3. 3
  4. 4
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المصدر: Universidad de La Sabana ; Intellectum Repositorio Universidad de La Sabana

    وصف الملف: application/pdf

    Relation: Neurobiology of Learning and Memory Volume 96, Issue 2, September 2011, Pages 272-279; Castiblanco-Piñeros, E., Quiroz-Padilla, MF., Cardenas-Palacio, CA., Cardenas, FP.(2011).Contribution of the parafascicular nucleus in the spontaneous object. Neurobiol Learn Mem.96, 272-279.; https://pubmed.ncbi.nlm.nih.gov/21624481/; http://hdl.handle.net/10818/55911

  8. 8
  9. 9
    Dissertation/ Thesis
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
  14. 14
  15. 15
    Academic Journal
  16. 16
    Electronic Resource
  17. 17
    Dissertation/ Thesis

    المساهمون: Múnera Galarza, Francisco Alejandro (Thesis advisor)

    وصف الملف: application/pdf

    Relation: Universidad Nacional de Colombia Sede Bogotá Facultad de Medicina; Facultad de Medicina; Cárdenas Palacio, Carlos Andrés (2010) Valoración de la sensibilidad cutánea en pacientes con parálisis facial periférica / Cutaneous sensibility ossessment in facial palsy patients. Maestría thesis, Universidad Nacional de Colombia.; https://repositorio.unal.edu.co/handle/unal/70388; http://bdigital.unal.edu.co/2653/

  18. 18
    Dissertation/ Thesis

    المؤلفون: Garcés Serna, Felipe

    المساهمون: Cárdenas Palacio, Carlos Andrés

    المصدر: Intellectum Repositorio Universidad de la Sabana ; Universidad de la Sabana

    Relation: Álvarez, J. (2000). Extasis sin Fe. Madrid: Trotta.; Bautista, S. J. (1853). Directorio místico. Gerona: Imprenta de la viuda e hijo de Figaró.; Benítez, L. (2011). Parapsicología de los milagros. España: Visión Libros.; Borriello, L., & Edmondo, C. (2002). Diccionario de Mística. Madrid: San Pablo.; Bouyer, L. (1990). Diccionario de Teología. Barcelona: Herder.; Caballo, V., Casal, G., & Carrobles, J. (1996). Manual de psicopatología y trastornos psiquiátricos. Madrid, España: España editores S.A.; Carvajal, C., Florenzano, R., & Weil, K. (2008). Psiquiatría. Santiago, Chile: Mediterráneo Ltda.; Castañón, R. (1996). Documentos para la ciencia y la Fe. La Paz: GIPLP.; De Ávila, T. (2006). Obras Completas de Santa Teresa de Jesús. Madrid: Biblioteca de Autores Cristianos; De la Cruz, J. (2011). Subida al Monte Carmelo. Ediciones Paulinas.; Freze, M. (1993). Voices, Visions and Apparitions. USA: Our Sunday Visitor.; Fuster, J. (2003). Cortex & Mind. Unifying Cognition. Inglaterra. Oxford University Press; Gelder, M., Mayou, R., & Geddes, J. (2000). Oxford psiquiatría. Madrid, España: Marban libros.; Hales, R. E., & Yudofsky, S. C. (2005). Tratado de Psiquiatría clínica. Barcelona: Masson.; Halgin, R., & Krauss, S. (2009). Psicología de la anormalidad. México DF: Mc Graw Hill.; Iglesia Católica. (2011). Catecismo de la Iglesia Católica. Vaticano: Librería Editrice Vaticana.; Jeeves, M., & Brown, W. (2010). Neurociencia, Psicología y Religión. Navarra: Verbo Divino.; Messori, V. (2013). Bernadette no nos engañó. España: Libros Libres.; Porter, C. (2004). Misterios de la Iglesia. Madrid: Editorial EDAF.; Rodríguez, M. I. (2011). Integrando la espiritualidad en la psicología. Burgos: Monte Carmelo.; Royo Marín, A. (1953). Teología de la Perfección Cristiana. Madrid: Editorial Católica.; Sarrais, F. (2011). Análisis psicológico del hombre. Navarra: Ediciones Universidad de Navarra.; Tanquerey, A. (2002). Compendio de Teología Ascética y Mística. Madrid: Ediciones Palabra.; Velazco, J. M. (2004). La experiencia mística. Estudio interdisciplinar. Madrid: Trotta.; Waters, F. (2010). Auditory Hallucinations in Psychiatric Illness. Psychiatric Times, 54-58.; http://hdl.handle.net/10818/21876; 176863; TE08016

  19. 19
    Dissertation/ Thesis

    المؤلفون: Garavito Escobar, Laura Paola

    المساهمون: Cárdenas Palacio, Carlos Andrés

    المصدر: Universidad de La Sabana ; Intellectum Repositorio Universidad de La Sabana

    مصطلحات موضوعية: Mialgia, Dolor crónico, Semiología (Medicina) -- Colombia

    Relation: Alvarez, M. (2008). Semiología clínica. Buenos Aires: Médica Panamericana.; Castro, J. & Benavides, M. (2005). Medicina del Dolor. Universidad del Rosario; Díaz, M., & Gérvas, J. (2002). El dolor lumbar. Semergen Medicina de Familia. 28(1). 21-41.; Maslo, P. (2001). Las dolencias de la espalda. Barcelona: editorial Paidotribo; Micheli, F. (2002). Tratado de neurología clínica. Buenos Aires: Ed Médica Panamericana.; Torres, M. & Compañ, V. (2006). La experiencia del Dolor. Barcelona: UOC.; Vértice, E. (2010). Salud pública y comunitaria. Madrid: Publicaciones Vértice.; Viñals, M. & Bueno, V. (2011). La experiencia del dolor. Editorial UOC.; http://hdl.handle.net/10818/21524; 176840; TE08384

  20. 20

    المؤلفون: Garavito Escobar, Laura Paola

    المساهمون: Cárdenas Palacio, Carlos Andrés

    المصدر: Universidad de La Sabana
    Intellectum Repositorio Universidad de La Sabana
    Repositorio Universidad de la Sabana
    Universidad de la Sabana
    instacron:Universidad de la Sabana

    مصطلحات موضوعية: Semiología (Medicina) -- Colombia, Mialgia, Dolor crónico